Skip to main content

Is My Product Recalled?

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Scan How It Works Saved Get Alerts

Menu

Search All Recalls Latest Recalls Scan Barcode Get Alerts

Categories

Food Recalls Medication Recalls Baby Products Pet Products Toys Electronics Household Vehicles Medical Devices Other

Resources

How Recalls Work FAQ Recall Classifications Statistics & Trends About

Your Recalls

Loading...

Stay Informed

Get email alerts when new recalls match your interests.

Recall data is updated hourly from official government sources. Very recent recalls may not yet appear. About our data sources

About

We make U.S. recall data searchable and accessible for consumers and businesses.

Site

FAQ
Browse by State
Statistics
Recall Classifications
About
Enterprise API

Legal

Privacy Policy
Terms of Service
Report Incorrect Info

Official Sources

FDA Recalls ↗
USDA FSIS ↗
CPSC Recalls ↗
NHTSA Recalls ↗

Home
/
Brands
/
Ranier's Compounding Laboratory

Ranier's Compounding Laboratory Recalls

All product recalls associated with Ranier's Compounding Laboratory.

Get alerts for this brand

Recall Summary

Total Recalls

15

Past Year

0

Class I (Serious)

0

Most Recent

Jul 2018

Data from FDA, USDA, CPSC, and NHTSA public records. Recall counts vary by company size, industry, and reporting practices. Always check official sources for current information.

Showing 1–15 of 15 recalls

PRASH Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Avastin Prefilled Syringe (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Vitamin D3 Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Moderate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

PRO/PA/PH/AT Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Dehydrated Alcohol Solution (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Triple P Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

P/P/P Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Acetylcysteine Oph Solution (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Papav/Phent Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Morphine Sulfate Inhalation (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

PR/PA/PH Injection (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Medroxprogesterone Ophthalmic Solution (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

DMSO Opth Solution (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

P/P/P Injection (Ranier's) – Sterility Concerns (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory

Atropine Opth Solution (Ranier's) – sterility concern (2018)

Lack of Assurance of Sterility: Practices at firm may call into question the sterility of products intended to be sterile.

Class IIModerate

FDAJul 25, 2018PA• Ranier's Compounding Laboratory